Clinical trial
Inactivated Bivalent Enterovirus Vaccine Phase I/II Clinical Trial: Open-Label Observation in Healthy Adults and Children, and Randomized, Double-Blind, Controlled Clinical Trial in Children
NCT06063057 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inactivated Bivalent Enterovirus Vaccine Phase I/II Clinical Trial: Open-Label Observation in Healthy Adults and Children, and Randomized, Double-Blind, Controlled Clinical Trial in Children
- Lead sponsor
- Sinovac Biotech Co., Ltd
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 20, 2023
- Completion date
- March 10, 2026
- Enrollment
- 744 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.